
Max Straka, Director, Drug Safety, at Leaderboard Branding, a Fingerpaint company, and previously served as a senior member of the FDA Division of Medication Error Prevention and Analysis (DMEPA) team
Advertisement
Articles by Max Straka, Director, Drug Safety, at Leaderboard Branding, a Fingerpaint company, and previously served as a senior member of the FDA Division of Medication Error Prevention and Analysis (DMEPA) team

Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Releases 2025 Financial Report and 2026 Sales and Operations Profit Outlook
2
Novartis’ Q4 Recap Shows Signs of Looming Patent Cliff
3
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
4
FDA Rejects AstraZeneca’s Application for Subcutaneous Indication of Saphnelo
5